Imricor Medical Systems, Inc. (ASX: IMR) | ARBN 633 106 019 400 Gateway Blvd. | Burnsville, Minnesota 55337 USA | +1 952.818.8400 | imricor.com FDA ACCEPTS IMRICOR’S PMA MANUFACTURING MODULE Key Highlights • The U.S. Food and Drug Administration (FDA) has...
FDA Accepts Imricor PMA Manufacturing Module
Filed with ASX ·
6ix hasn’t read this filing yet.
Imricor Medical Systems, Inc. on 6ix
Earlier from Imricor Medical Systems
- Release from Voluntary Escrow
- Imricor and Philips Launch Commercial iMR Lab Solution
- Imricor U.S. Commercial Momentum Accelerates
- 1H 2026 Investor Presentation
- 2026 Q2 Form 10-Q
Later from Imricor Medical Systems
- S&P DJI Announces September 2026 Quarterly Rebalance
- Application for quotation of securities - IMR
- Cleansing Notice
- FDA Completes Review of Third PMA Module
- Notification regarding unquoted securities - IMR
Follow Imricor Medical Systems into a list and get an email when it puts out news.
Follow Imricor Medical Systems